DHR
Price
$206.88
Change
+$3.94 (+1.94%)
Updated
Jul 29, 04:59 PM (EDT)
Capitalization
184.93B
91 days until earnings call
LZAGY
Price
$70.26
Change
-$1.34 (-1.87%)
Updated
Jul 28 closing price
Capitalization
43.14B
84 days until earnings call
Interact to see
Advertisement

DHR vs LZAGY

Header iconDHR vs LZAGY Comparison
Open Charts DHR vs LZAGYBanner chart's image
Danaher
Price$206.88
Change+$3.94 (+1.94%)
Volume$63.24K
Capitalization184.93B
Lonza Group AG
Price$70.26
Change-$1.34 (-1.87%)
Volume$24.72K
Capitalization43.14B
DHR vs LZAGY Comparison Chart in %
Loading...
DHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LZAGY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DHR vs. LZAGY commentary
Jul 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DHR is a Buy and LZAGY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 30, 2025
Stock price -- (DHR: $202.94 vs. LZAGY: $70.26)
Brand notoriety: DHR and LZAGY are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: DHR: 129% vs. LZAGY: 34%
Market capitalization -- DHR: $184.93B vs. LZAGY: $43.14B
DHR [@Medical Specialties] is valued at $184.93B. LZAGY’s [@Medical Specialties] market capitalization is $43.14B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DHR’s FA Score shows that 0 FA rating(s) are green whileLZAGY’s FA Score has 1 green FA rating(s).

  • DHR’s FA Score: 0 green, 5 red.
  • LZAGY’s FA Score: 1 green, 4 red.
According to our system of comparison, LZAGY is a better buy in the long-term than DHR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DHR’s TA Score shows that 6 TA indicator(s) are bullish while LZAGY’s TA Score has 3 bullish TA indicator(s).

  • DHR’s TA Score: 6 bullish, 3 bearish.
  • LZAGY’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, DHR is a better buy in the short-term than LZAGY.

Price Growth

DHR (@Medical Specialties) experienced а +7.91% price change this week, while LZAGY (@Medical Specialties) price change was +0.31% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.45%. For the same industry, the average monthly price growth was +2.22%, and the average quarterly price growth was -4.55%.

Reported Earning Dates

DHR is expected to report earnings on Oct 28, 2025.

LZAGY is expected to report earnings on Oct 21, 2025.

Industries' Descriptions

@Medical Specialties (-1.45% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DHR($185B) has a higher market cap than LZAGY($43.1B). DHR has higher P/E ratio than LZAGY: DHR (43.86) vs LZAGY (32.68). LZAGY YTD gains are higher at: 21.209 vs. DHR (-11.317). DHR has higher annual earnings (EBITDA): 7.5B vs. LZAGY (1.42B). DHR has more cash in the bank: 5.86B vs. LZAGY (2.15B). LZAGY has less debt than DHR: LZAGY (2.91B) vs DHR (19.5B). DHR has higher revenues than LZAGY: DHR (23.9B) vs LZAGY (6.32B).
DHRLZAGYDHR / LZAGY
Capitalization185B43.1B429%
EBITDA7.5B1.42B529%
Gain YTD-11.31721.209-53%
P/E Ratio43.8632.68134%
Revenue23.9B6.32B378%
Total Cash5.86B2.15B273%
Total Debt19.5B2.91B670%
FUNDAMENTALS RATINGS
DHR vs LZAGY: Fundamental Ratings
DHR
LZAGY
OUTLOOK RATING
1..100
1056
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
22
Undervalued
PROFIT vs RISK RATING
1..100
6769
SMR RATING
1..100
7893
PRICE GROWTH RATING
1..100
6152
P/E GROWTH RATING
1..100
7182
SEASONALITY SCORE
1..100
3450

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LZAGY's Valuation (22) in the null industry is somewhat better than the same rating for DHR (58) in the Medical Specialties industry. This means that LZAGY’s stock grew somewhat faster than DHR’s over the last 12 months.

DHR's Profit vs Risk Rating (67) in the Medical Specialties industry is in the same range as LZAGY (69) in the null industry. This means that DHR’s stock grew similarly to LZAGY’s over the last 12 months.

DHR's SMR Rating (78) in the Medical Specialties industry is in the same range as LZAGY (93) in the null industry. This means that DHR’s stock grew similarly to LZAGY’s over the last 12 months.

LZAGY's Price Growth Rating (52) in the null industry is in the same range as DHR (61) in the Medical Specialties industry. This means that LZAGY’s stock grew similarly to DHR’s over the last 12 months.

DHR's P/E Growth Rating (71) in the Medical Specialties industry is in the same range as LZAGY (82) in the null industry. This means that DHR’s stock grew similarly to LZAGY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DHRLZAGY
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
59%
Bearish Trend 2 days ago
58%
Momentum
ODDS (%)
Bullish Trend 2 days ago
62%
Bearish Trend 2 days ago
54%
MACD
ODDS (%)
Bullish Trend 2 days ago
65%
Bearish Trend 2 days ago
53%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
58%
Bullish Trend 2 days ago
58%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
57%
Bullish Trend 2 days ago
58%
Advances
ODDS (%)
Bullish Trend 5 days ago
54%
Bullish Trend 7 days ago
56%
Declines
ODDS (%)
Bearish Trend 9 days ago
59%
Bearish Trend 15 days ago
55%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
70%
Bearish Trend 2 days ago
47%
Aroon
ODDS (%)
Bullish Trend 2 days ago
60%
Bullish Trend 2 days ago
54%
View a ticker or compare two or three
Interact to see
Advertisement
DHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LZAGY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MMLP2.80N/A
N/A
Martin Midstream Partners LP
ACCO4.00N/A
N/A
Acco Brands Corp
GFL48.13-0.09
-0.19%
GFL Environmental
EVOK4.36-0.07
-1.58%
Evoke Pharma, Inc.
IBRX2.65-0.21
-7.34%
ImmunityBio

LZAGY and

Correlation & Price change

A.I.dvisor indicates that over the last year, LZAGY has been loosely correlated with LZAGF. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if LZAGY jumps, then LZAGF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LZAGY
1D Price
Change %
LZAGY100%
-1.87%
LZAGF - LZAGY
62%
Loosely correlated
-2.63%
TMO - LZAGY
42%
Loosely correlated
+1.39%
SOAGY - LZAGY
41%
Loosely correlated
-0.51%
CRL - LZAGY
37%
Loosely correlated
+1.16%
DHR - LZAGY
36%
Loosely correlated
-1.24%
More